Tiefenbacher

Tiefenbacher

Hamburg, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Tiefenbacher Group is a long-established, fully integrated pharmaceutical services and manufacturing company headquartered in Hamburg, Germany. With over 900 employees, it provides end-to-end solutions from API sourcing to product development, manufacturing, and commercialization, serving more than 400 customers in over 80 countries. The company is purpose-driven, focusing on improving global access to affordable medicines and medical devices, and claims its products reach over 500 million patients. As a private, family-owned entity, it combines decades of operational expertise with a patient-centric mission.

Drug DeliveryMedical Devices

Technology Platform

Integrated pharmaceutical value chain services platform encompassing raw material distribution, R&D, manufacturing, and market entry support.

Opportunities

Growing global demand for affordable generic and value-added medicines, especially in emerging markets, drives need for its integrated development and manufacturing services.
Expansion into complex formulations, biosimilars, and digital health adjacencies presents significant growth avenues.

Risk Factors

Faces intense competition from large CDMOs and generic manufacturers, which could pressure margins.
Operational risks include supply chain volatility, regulatory compliance at manufacturing sites, and geopolitical instability affecting its global footprint.

Competitive Landscape

Competes with large global Contract Development and Manufacturing Organizations (CDMOs) like Lonza, Catalent, and Siegfried, as well as other integrated pharmaceutical service providers and generic drug manufacturers. Its differentiation lies in its full value-chain integration, family-owned long-term focus, and stated patient-centric purpose.